Topical ophthalmic amethocaine alleviates trigeminal neuralgia pain
Silviu Brill1, Ron Ben-Abraham1, Itay Goor-Aryeh2
1Pain Clinic, Tel-Aviv Medical Center, Tel-Aviv, Israel; 2Pain Clinic Sheba Medical Center, Tel-Hashomer, Israel
Background: Trigeminal neuralgia (TGN) is a challenging pain syndrome.
Aim: To test the effectiveness of local instillation of ophthalmic solution of amethocaine in relieving the pain of TGN.
Methods: We performed an open-label prospective study in 40 consecutive currently treated patients suffering from TGN with a reported visual analog scale (VAS) >8 (severe pain). The patients received two drops of amethocaine 1% instilled on the cornea ipsilateral to the painful side. Pain score assessment using VAS was recorded pre- and post-treatment.
Results: A total of 32 (80%) patients reported a significant reduction in pain 10 minutes after drops instillation as compared with pre-treatment pain score. Pre-treatment VAS score was 8.53 ± 0.6 as compared with 4.78 ± 1.83 post-amethocaine treatments (P < 0.00001).
Conclusion: Topical ophthalmic instillation of amethocaine 1% can be considered as an immediate effective method for pain paroxysm of TGN.
Keywords: amethocaine, trigeminal neuralgia, pain, opthalmic
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]